Page last updated: 2024-10-19

melatonin and Hypergonadotropic Hypogonadism

melatonin has been researched along with Hypergonadotropic Hypogonadism in 28 studies

Research Excerpts

ExcerptRelevanceReference
"The endocrine system of aging males reveals changes of more or less unknown significance for estrogens, dehydroepiandrosterone (DHEA), melatonin and growth hormone."8.82[Hormone therapy in the aging male. Estrogen, DHEA, melatonin, somatotropin]. ( Kliesch, S, 2004)
"Elevated nocturnal melatonin is found in women with idiopathic hypogonadotropic hypogonadism (IHH), but it is not known whether this is implicated in the etiology of their GnRH deficiency."7.70Elevated nocturnal melatonin is a consequence of gonadotropin-releasing hormone deficiency in women with hypothalamic amenorrhea. ( Di, WL; Djahanbakhch, O; Kadva, A; Monson, J; Silman, R, 1998)
"Increased melatonin secretion observed in male patients with congenital isolated hypogonadotropic hypogonadism and its normalization during testosterone treatment had suggested that melatonin and the reproductive hormones are inter-related."7.70Melatonin hypersecretion in male patients with adult-onset idiopathic hypogonadotropic hypogonadism. ( Ishai, A; Lavie, P; Luboshitzky, R; Shen-Orr, Z, 2000)
"It has previously been shown that increased nocturnal melatonin (MT) secretion exists in male patients with hypogonadotropic hypogonadism."7.69Daytime plasma melatonin levels in male hypogonadism. ( Beyhan, Z; Bingol, N; Bolu, E; Bulur, M; Corakci, A; Gundogan, MA; Ozata, M, 1996)
"The endocrine system of aging males reveals changes of more or less unknown significance for estrogens, dehydroepiandrosterone (DHEA), melatonin and growth hormone."4.82[Hormone therapy in the aging male. Estrogen, DHEA, melatonin, somatotropin]. ( Kliesch, S, 2004)
"Elevated nocturnal melatonin is found in women with idiopathic hypogonadotropic hypogonadism (IHH), but it is not known whether this is implicated in the etiology of their GnRH deficiency."3.70Elevated nocturnal melatonin is a consequence of gonadotropin-releasing hormone deficiency in women with hypothalamic amenorrhea. ( Di, WL; Djahanbakhch, O; Kadva, A; Monson, J; Silman, R, 1998)
"Increased melatonin secretion observed in male patients with congenital isolated hypogonadotropic hypogonadism and its normalization during testosterone treatment had suggested that melatonin and the reproductive hormones are inter-related."3.70Melatonin hypersecretion in male patients with adult-onset idiopathic hypogonadotropic hypogonadism. ( Ishai, A; Lavie, P; Luboshitzky, R; Shen-Orr, Z, 2000)
"It has previously been shown that increased nocturnal melatonin (MT) secretion exists in male patients with hypogonadotropic hypogonadism."3.69Daytime plasma melatonin levels in male hypogonadism. ( Beyhan, Z; Bingol, N; Bolu, E; Bulur, M; Corakci, A; Gundogan, MA; Ozata, M, 1996)
"To clarify whether disorders of gonadotropin releasing hormone (GnRH) deficiency are associated with altered melatonin and pituitary hormones secretory patterns, we studied male patients with hypogonadotropic hypogonadism (IGD; n = 6), delayed puberty (DP; n = 7) and age-matched pubertal controls (n = 7)."3.69Nocturnal secretory patterns of melatonin, luteinizing hormone, prolactin and cortisol in male patients with gonadotropin-releasing hormone deficiency. ( Herer, P; Lavi, S; Lavie, P; Luboshitzky, R; Thuma, I, 1996)
"Circadian serum melatonin profiles were studied in six men with primary hypogonadism before and during testosterone substitution and compared with an age-matched control group (n = 6)."3.69Melatonin concentration before and during testosterone replacement in primary hypogonadic men. ( de Leiva, A; García Patterson, A; Puig-Domingo, M; Rajmil, O; Schwarzstein, D; Tortosa, F; Viader, M, 1997)
"Pretreatment melatonin levels in IGD were greater than those in age-matched pubertal controls while in KS, melatonin levels were lower than values in controls."2.68Abnormal melatonin secretion in hypogonadal men: the effect of testosterone treatment. ( Herer, P; Lavi, S; Lavie, P; Luboshitzky, R; Wagner, O, 1997)
"Melatonin is a hormone mainly secreted by the pineal gland during the dark phase of the light-dark cycle."2.41[Melatonin. I. Physiology of its secretion]. ( Bruls, E; Crasson, M; Legros, JJ, 2000)
"Male patients with hypogonadotropic hypogonadism (IGD, n = 6), constitutional delayed puberty (DP, n = 6), and Klinefelter's syndrome (KS, n = 5) before and during testosterone replacement therapy were studied."1.30The association between melatonin and sleep stages in normal adults and hypogonadal men. ( Lavi, S; Lavie, P; Luboshitzky, R, 1999)
"Melatonin levels were equal in patients and controls when T and E2 levels were well matched."1.29Testosterone treatment alters melatonin concentrations in male patients with gonadotropin-releasing hormone deficiency. ( Lavi, S; Lavie, P; Luboshitzky, R; Thuma, I, 1996)

Research

Studies (28)

TimeframeStudies, this research(%)All Research%
pre-19903 (10.71)18.7374
1990's18 (64.29)18.2507
2000's5 (17.86)29.6817
2010's2 (7.14)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, C1
Ling, MY1
Lin, FH1
Xu, L1
Lv, ZM1
Smith, RP1
Coward, RM1
Kovac, JR1
Lipshultz, LI1
Cuzin, B1
Giuliano, F1
Jamin, Ch1
Legros, JJ2
Lejeune, H1
Rigot, JM1
Roger, M1
Kliesch, S1
Kumanov, P1
Tomova, A1
Isidori, A1
Nordio, M1
Luboshitzky, R8
Lavi, S6
Thuma, I3
Lavie, P9
Nir, I1
Schmidt, U1
Zilber, N1
Ozata, M2
Bulur, M1
Bingol, N1
Beyhan, Z2
Corakci, A1
Bolu, E1
Gundogan, MA1
Herer, P4
Wagner, O2
Luboshitsky, R1
Walker, AB1
English, J1
Arendt, J2
MacFarlane, IA1
Rajmil, O1
Puig-Domingo, M2
Tortosa, F1
Viader, M1
García Patterson, A1
Schwarzstein, D1
de Leiva, A2
Leibenluft, E1
Schmidt, PJ1
Turner, EH1
Danaceau, MA1
Ashman, SB1
Wehr, TA1
Rubinow, DR1
Kadva, A1
Djahanbakhch, O1
Monson, J1
Di, WL1
Silman, R1
Manber, R1
Armitage, R1
Shen-Orr, Z1
Ishai, A1
Bruls, E1
Crasson, M1
Webb, SM1
Serrano, J1
Peinado, MA1
Corcoy, R1
Ruscalleda, J1
Reiter, RJ1
Utiger, RD1
Labib, MH1
Bojkowski, C1
Hanson, S1
Marks, V1
Grishchenko, VI1
Zubkov, GV1
Berg, GR1
Klein, DC1

Clinical Trials (3)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Chronobiologic Effects of Gonadal Steroid Manipulations in Volunteer Subjects[NCT00001285]73 participants Observational1991-08-31Completed
A Mechanistic Examination of Continuous Cycle Oral Contractive Administration in Binge Eating[NCT04278755]Phase 28 participants (Actual)Interventional2020-09-24Terminated (stopped due to Halted prematurely due to COVID-19-related enrollment challenges.)
Characterizing the Neural Substrates of Irritability in Women: an Experimental Neuroendocrine Model[NCT04051320]Phase 223 participants (Actual)Interventional2020-01-02Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Change From Pre-intervention to Intervention Endpoint in Behavioral Inhibition Subscale Score

The Behavioral Inhibition/Behavioral Activation questionnaire will be used to assess behavioural inhibition (BI). The minimum score on the BI subscale is 7, maximum 28. Greater scores indicate greater BI. Change is defined as the average change in BI from pre-intervention to intervention. (NCT04278755)
Timeframe: Pre-intervention (week 1) to intervention endpoint (week 12)

Interventionscore on a scale (Mean)
Continuous OC1.43

Change From Pre-intervention to Intervention Endpoint in Binge Eating Sum Score

"Binge eating will be measured using the 8-item binge eating subscale of the Eating Pathology Symptoms Inventory (EPSI), which measures features of binge eating (e.g., consumption of large quantities of food, mindless eating) on a 5-point Likert scale from never to very often. The EPSI scale is designed to assess behavior over the past 28 days. Items are summed for a scale score ranging from 0-32. Higher scores indicate more frequent experiences with binge eating behavior. Change is defined as the average change in the binge eating scale score from pre-intervention to intervention." (NCT04278755)
Timeframe: Pre-intervention (week 1) to intervention endpoint (week 12)

Interventionscore on a scale (Mean)
Continuous OC-6.60

Change From Pre-intervention to Intervention Endpoint in Delay Discounting Parameter k

The Monetary Choice Questionnaire will be used to measure delay discounting. Participants will be asked to make a series of hypothetical choices between small, sooner (impulsive) vs. larger, later (self controlled) hypothetical monetary outcomes. k is a hyperbolic function with larger k values indicating more valuation of a larger delayed reward and smaller values indicating preference for more immediate, smaller rewards (more impulsivity). k can range from 0 to .25 with scores of .25 indicating complete valuation of the immediate reward and 0 indicating complete valuation of the larger, delayed reward. Change is defined as the average change in k from pre-intervention to intervention. (NCT04278755)
Timeframe: Pre-intervention (week 1) to intervention endpoint (week 12)

Interventionk value (Mean)
Continuous OC.01

Change From Pre-intervention to Intervention Endpoint in Nucleus Accumbens Signal Intensity in Response to Reward During the Monetary Incentive Delay Task (MIDT)

"Nucleus Accumbens (NAcc) reactivity to reward during the Monetary Incentive Delay (MIDT) task compared pre and post treatment. During MIDT task, participants respond to win trials by pressing a button on a button box in the MRI as quickly as possible when they see a target. Reactivity is measured by examining participant's change in blood-oxygen-level dependent (BOLD) (i.e., measurement of oxygen level that is carried to neurons by red blood cells since areas of the brain that are thought to be more active or involved in certain tasks require more oxygen) in response to a stimulus of interest (win trials) versus non-stimulus (non-win trials). Percent signal change in BOLD activation between monetary reward versus non-reward is the outcome of interest. Percent signal change is then compared pre- and post-treatment." (NCT04278755)
Timeframe: Pre-intervention (week 1) to intervention endpoint (week 12)

Interventionpercentage signal change (Mean)
Continuous OC.0423

Change From Pre-intervention to Intervention Endpoint in Prefrontal Cortex Signal Intensity in Response to Reward During the Monetary Incentive Delay Task (MIDT)

"Prefrontal cortex reactivity to reward during the Monetary Incentive Delay (MIDT) task compared pre and post treatment. During MIDT task, participants respond to win trials by pressing a button on a button box in the MRI as quickly as possible when they see a target. Reactivity is measured by examining participant's change in blood-oxygen-level dependent (BOLD) (i.e., measurement of oxygen level that is carried to neurons by red blood cells since areas of the brain that are thought to be more active or involved in certain tasks require more oxygen) in response to a stimulus of interest (win trials) versus non-stimulus (non-win trials). Percent signal change in BOLD activation between monetary reward versus non-reward is the outcome of interest. Percent signal change is then compared pre- and post-treatment." (NCT04278755)
Timeframe: Pre-intervention (week 1) to intervention endpoint (week 12)

Interventionpercentage signal change (Mean)
Continuous OC.01

Change From Pre-intervention to Intervention Endpoint in Self-reported Reward Sensitivity Subscale Score

Sensitivity to Punishment/Sensitivity to Reward Questionnaire will be used to measure reward sensitivity. The reward sensitivity subscale will be used, which is rated on a true/false scale with scores ranging 0-24. Higher scores indicate more sensitivity to reward. Change is defined as the average change in reward sensitivity from pre-intervention to intervention. (NCT04278755)
Timeframe: Pre-intervention (week 1) to intervention endpoint (week 12)

Interventionscore on a scale (Mean)
Continuous OC1.60

Change From Pre-intervention to Intervention Endpoint in Weekly Average Binge-eating Frequency

Binge eating frequency is based on a weekly diary of self-reported binge eating frequency. Participants were asked how many times during the past week they had a binge eating episode. Scores can range from 0 to infinity as frequency is self-reported as the number of binge eating episodes in the previous week. Higher scores indicate more episodes of binge eating. Change is defined as the average change in self-reported binge eating frequency from pre-intervention to intervention. (NCT04278755)
Timeframe: Pre-intervention (week 1) to intervention endpoint (week 12)

Interventionepisodes/week (Mean)
Continuous OC-0.43

Change From Pre-intervention to Intervention Endpoint in Dorsal Striatum Signal Intensity in Response to Reward During the Monetary Incentive Delay Task (MIDT)

"Dorsal striatum reactivity (defined as caudate signal intensity and putamen signal intensity) to reward during the Monetary Incentive Delay (MIDT) task compared pre and post treatment. During MIDT task, participants respond to win trials by pressing a button on a button box in the MRI as quickly as possible when they see a target. Reactivity is measured by examining participant's change in blood-oxygen-level dependent (BOLD) (i.e., measurement of oxygen level that is carried to neurons by red blood cells since areas of the brain that are thought to be more active or involved in certain tasks require more oxygen) in response to a stimulus of interest (win trials) versus non-stimulus (non-win trials). Percent signal change in BOLD activation between monetary reward versus non-reward is the outcome of interest. Percent signal change is then compared pre- and post-treatment." (NCT04278755)
Timeframe: Pre-intervention (week 1) to intervention endpoint (week 12)

Interventionpercentage signal change (Mean)
CaudatePutamen
Continuous OC-.012.02

Correlation Between Irritability and Reactive Aggression During Hormone Addback

"This outcome measure determines the degree of irritability and reactive aggression in HS+ during hormone addback and its relationship to the target population. Irritability will be defined as score on the IDAS Ill Temper Scale. Reactive aggression will be defined as the number of point subtractions the participant makes during the Point Subtraction Aggression Paradigm.~The Point Subtraction Aggression Paradigm measures relational aggression (approach behavior) in response to frustration. In the task, participants are asked to press a button to ac" (NCT04051320)
Timeframe: Endpoint (week 6)

Interventioncorrelation coefficient (Number)
Hormone Sensitive Women (HS+)0.18
Hormone Insensitive Women (HS-)0.03

Correlation Between Irritability Subcortical Activation in HS+ During Hormone Addback

"This outcome measure determines the degree of subcortical (amygdala, caudate, putamen, and nucleus accumbens) activation in HS+ during hormone addback and it's relationship to the target population. The activation in amygdala and ventral striatum (caudate, putamen, nucleus accumbens) regions of interest (ROIs) will be assessed during the Affective Posner Task.~The Affective Posner Task tests whether HS+ is characterized by reduced subcortical activation in response to frustration. This task is divided into 3 runs: during Run 1 (practice run), participants receive accurate feedback about their performance on the task and do not win or lose money; during Run 2, participants receive accurate feedback about their performance and win or lose 50 cents per trial; and during Run 3 (frustration), participants are told they must respond accurately to win money, but participants are given feedback that they responded too slowly on 60% of accurate trials, regardless of their performance." (NCT04051320)
Timeframe: Endpoint (week 6)

Interventioncorrelation coefficient (Number)
Hormone Sensitive Women (HS+)0.47

Correlation Between the Inventory of Depressive and Anxiety Symptoms (IDAS) Ill -0.8Scale and Threat Attention Bias

This outcome measure determines the extent to which irritability is characterized by dysfunctional reward processing during reproductive hormone challenge in HS+ and HS- by examining the correlation between the Inventory of Depressive and Anxiety Symptoms (IDAS) Ill Temper (i.e., irritability) Scale and threat attention bias. (NCT04051320)
Timeframe: Endpoint (week 6)

Interventioncorrelation coefficient (Number)
Hormone Sensitive Women (HS+)-0.35
Hormone Insensitive Women (HS-)0.11

Correlation Between the Inventory of Depressive and Anxiety Symptoms (IDAS) Ill Temper Scale and Left Amygdala-medial Prefrontal Cortex (PFC) BOLD Connectivity.

This outcome measure determines the extent to which irritability is characterized by dysfunctional reward processing during reproductive hormone challenge in HS+ and HS- by examining the correlation between the IDAS Ill Temper (i.e., irritability) Scale and amygdala-medial PFC connectivity in HS+. (NCT04051320)
Timeframe: Endpoint (week 6)

Interventioncorrelation coefficient (Mean)
Hormone Sensitive Women (HS+)-0.13
Hormone Insensitive Women (HS-)0.49

Correlation Between the Inventory of Depressive and Anxiety Symptoms (IDAS) Ill Temper Scale and Right Amygdala-medial Prefrontal Cortex (PFC) BOLD Connectivity.

This outcome measure determines the extent to which irritability is characterized by dysfunctional reward processing during reproductive hormone challenge in HS+ and HS- by examining the correlation between the IDAS Ill Temper (i.e., irritability) Scale and amygdala-medial PFC connectivity in HS+. (NCT04051320)
Timeframe: Endpoint (week 6)

Interventioncorrelation coefficient (Number)
Hormone Sensitive Women (HS+)-0.57
Hormone Insensitive Women (HS-)-0.08

Mean BOLD Activation of the Left Amygdala During the Affective Posner Task Over Time

"This outcome measure determines the extent to which HS+ is characterized by BOLD activation of the left amygdala in response to frustrative non-reward (FNR) in the Affective Posner Task during hormone addback relative to baseline in the target population.~The Affective Posner Task tests whether HS+ is characterized by reduced subcortical activation in response to frustration. This task is divided into 3 runs: during Run 1 (practice run), participants receive accurate feedback about their performance on the task and do not win or lose money; during Run 2, participants receive accurate feedback about their performance and win or lose 50 cents per trial; and during Run 3 (frustration), participants are told they must respond accurately to win money, but participants are given feedback that they responded too slowly on 60% of accurate trials, regardless of their performance." (NCT04051320)
Timeframe: up to 6 weeks

,
InterventionArbitrary Units (Mean)
Baseline (Visit 3)Hormone Addback (Visit 6)
Hormone Insensitive Women (HS-)-0.009866667-0.086876444
Hormone Sensitive Women (HS+)0.005316917-0.047401917

Mean BOLD Activation of the Left Caudate During the Affective Posner Task Over Time

"This outcome measure determines the extent to which HS+ is characterized by BOLD activation of the left caudate in response to frustrative non-reward (FNR) in the Affective Posner Task during hormone addback relative to baseline in the target population.~The Affective Posner Task tests whether HS+ is characterized by reduced subcortical activation in response to frustration. This task is divided into 3 runs: during Run 1 (practice run), participants receive accurate feedback about their performance on the task and do not win or lose money; during Run 2, participants receive accurate feedback about their performance and win or lose 50 cents per trial; and during Run 3 (frustration), participants are told they must respond accurately to win money, but participants are given feedback that they responded too slowly on 60% of accurate trials, regardless of their performance." (NCT04051320)
Timeframe: up to 6 weeks

,
InterventionArbitrary Units (Mean)
Baseline (Visit 3)Hormone Addback (Visit 6)
Hormone Insensitive Women (HS-)0.0077258-0.049988
Hormone Sensitive Women (HS+)-0.0439433330.059099917

Mean BOLD Activation of the Left Nucleus Accumbens During the Affective Posner Task Over Time

"This outcome measure determines the extent to which HS+ is characterized by BOLD activation of the left nucleus accumbens in response to frustrative non-reward (FNR) in the Affective Posner Task during hormone addback relative to baseline in the target population.~The Affective Posner Task tests whether HS+ is characterized by reduced subcortical activation in response to frustration. This task is divided into 3 runs: during Run 1 (practice run), participants receive accurate feedback about their performance on the task and do not win or lose money; during Run 2, participants receive accurate feedback about their performance and win or lose 50 cents per trial; and during Run 3 (frustration), participants are told they must respond accurately to win money, but participants are given feedback that they responded too slowly on 60% of accurate trials, regardless of their performance." (NCT04051320)
Timeframe: up to 6 weeks

,
InterventionArbitrary Units (Mean)
Baseline (Visit 3)Hormone Addback (Visit 6)
Hormone Insensitive Women (HS-)0.0691907-0.072512
Hormone Sensitive Women (HS+)-0.0284518180.031632727

Mean BOLD Activation of the Left Putamen During the Affective Posner Task Over Time

"This outcome measure determines the extent to which HS+ is characterized by BOLD activation of the left putamen in response to frustrative non-reward (FNR) in the Affective Posner Task during hormone addback relative to baseline in the target population.~The Affective Posner Task tests whether HS+ is characterized by reduced subcortical activation in response to frustration. This task is divided into 3 runs: during Run 1 (practice run), participants receive accurate feedback about their performance on the task and do not win or lose money; during Run 2, participants receive accurate feedback about their performance and win or lose 50 cents per trial; and during Run 3 (frustration), participants are told they must respond accurately to win money, but participants are given feedback that they responded too slowly on 60% of accurate trials, regardless of their performance." (NCT04051320)
Timeframe: up to 6 weeks

,
InterventionArbitrary Units (Mean)
Baseline (Visit 3)Hormone Addback (Visit 6)
Hormone Insensitive Women (HS-)0.0383029-0.021029
Hormone Sensitive Women (HS+)-0.0012234620.048155385

Mean BOLD Activation of the Right Amygdala During the Affective Posner Task Over Time

"This outcome measure determines the extent to which HS+ is characterized by BOLD activation of the right amygdala in response to frustrative non-reward (FNR) in the Affective Posner Task during hormone addback relative to baseline in the target population.~The Affective Posner Task tests whether HS+ is characterized by reduced subcortical activation in response to frustration. This task is divided into 3 runs: during Run 1 (practice run), participants receive accurate feedback about their performance on the task and do not win or lose money; during Run 2, participants receive accurate feedback about their performance and win or lose 50 cents per trial; and during Run 3 (frustration), participants are told they must respond accurately to win money, but participants are given feedback that they responded too slowly on 60% of accurate trials, regardless of their performance." (NCT04051320)
Timeframe: up to 6 weeks

,
InterventionArbitrary Units (Mean)
Baseline (Visit 3)Hormone Addback (Visit 6)
Hormone Insensitive Women (HS-)0.037334-0.15643
Hormone Sensitive Women (HS+)-0.045440.022654

Mean BOLD Activation of the Right Caudate During the Affective Posner Task Over Time

"This outcome measure determines the extent to which HS+ is characterized by BOLD activation of the right caudate in response to frustrative non-reward (FNR) in the Affective Posner Task during hormone addback relative to baseline in the target population.~The Affective Posner Task tests whether HS+ is characterized by reduced subcortical activation in response to frustration. This task is divided into 3 runs: during Run 1 (practice run), participants receive accurate feedback about their performance on the task and do not win or lose money; during Run 2, participants receive accurate feedback about their performance and win or lose 50 cents per trial; and during Run 3 (frustration), participants are told they must respond accurately to win money, but participants are given feedback that they responded too slowly on 60% of accurate trials, regardless of their performance." (NCT04051320)
Timeframe: up to 6 weeks

,
InterventionArbitrary Units (Mean)
Baseline (Visit 3)Hormone Addback (Visit 6)
Hormone Insensitive Women (HS-)0.0614070.0058011
Hormone Sensitive Women (HS+)-0.0699190770.045146154

Mean BOLD Activation of the Right Nucleus Accumbens During the Affective Posner Task Over Time

"This outcome measure determines the extent to which HS+ is characterized by BOLD activation of the right nucleus accumbens in response to frustrative non-reward (FNR) in the Affective Posner Task during hormone addback relative to baseline in the target population.~The Affective Posner Task tests whether HS+ is characterized by reduced subcortical activation in response to frustration. This task is divided into 3 runs: during Run 1 (practice run), participants receive accurate feedback about their performance on the task and do not win or lose money; during Run 2, participants receive accurate feedback about their performance and win or lose 50 cents per trial; and during Run 3 (frustration), participants are told they must respond accurately to win money, but participants are given feedback that they responded too slowly on 60% of accurate trials, regardless of their performance." (NCT04051320)
Timeframe: up to 6 weeks

,
InterventionArbitrary Units (Mean)
Baseline (Visit 3)Hormone Addback (Visit 6)
Hormone Insensitive Women (HS-)0.052685333-0.006394444
Hormone Sensitive Women (HS+)0.044384167-0.005181667

Mean BOLD Activation of the Right Putamen During the Affective Posner Task Over Time

"This outcome measure determines the extent to which HS+ is characterized by BOLD activation of the right putamen in response to frustrative non-reward (FNR) in the Affective Posner Task during hormone addback relative to baseline in the target population.~The Affective Posner Task tests whether HS+ is characterized by reduced subcortical activation in response to frustration. This task is divided into 3 runs: during Run 1 (practice run), participants receive accurate feedback about their performance on the task and do not win or lose money; during Run 2, participants receive accurate feedback about their performance and win or lose 50 cents per trial; and during Run 3 (frustration), participants are told they must respond accurately to win money, but participants are given feedback that they responded too slowly on 60% of accurate trials, regardless of their performance." (NCT04051320)
Timeframe: up to 6 weeks

,
InterventionArbitrary Units (Mean)
Baseline (Visit 3)Hormone Addback (Visit 6)
Hormone Insensitive Women (HS-)0.002542222-0.080736333
Hormone Sensitive Women (HS+)-0.0075606920.036225385

Mean Left Amygdala-medial Prefrontal Cortex BOLD Connectivity During Implicit Emotion Face Processing Task Over Time

"This outcome measure determines the extent to which irritability is characterized by dysfunctional threat processing during reproductive hormone challenge relative to baseline in HS+ and HS-. By examining amygdala-medial prefrontal cortex (PFC) connectivity in response to threatening faces on the implicit emotion face processing fMRI task in HS+ (compared with HS-) during hormone challenge relative to baseline.~The implicit emotion face processing task asks participants to identify the gender of angry, happy, and fearful faces at 50%, 100% and 150% emotion intensity presented in random order for 2000 milliseconds followed by jittered fixation. Trials appear in 3 blocks, generating 30 trials of each emotion at each intensity and 90 neutral face emotion trials." (NCT04051320)
Timeframe: up to 6 weeks

,
Interventionarbitrary units (Mean)
Baseline (Visit 3)Hormone Addback (Visit 6)
Hormone Insensitive Women (HS-)0.02130.00111
Hormone Sensitive Women (HS+)0.0247-0.0192

Mean Reactive Aggression During Hormone Addback Over Time

"This outcome measure determines the extent to which HS+ is characterized by reactive aggression during hormone addback relative to baseline in the target population. Reactive aggression will be defined as the number of point subtractions the participant makes during the Point Subtraction Aggression Paradigm.~Point Subtraction Aggression Paradigm measures relational aggression (approach behavior) in response to frustration. In the task, participants are asked to press a button to accrue money or press another button to subtract money from a (fictional) partner at no direct gain to themselves. Frustration is induced by periodic subtractions of their own money, which is attributed to the partner." (NCT04051320)
Timeframe: up to 6 weeks

,
InterventionNumber of subtraction responses (Mean)
Baseline (Visit 3)Hormone Addback (Visit 6)
Hormone Insensitive Women (HS-)129.2054.90
Hormone Sensitive Women (HS+)103.0834.62

Mean Right Amygdala-medial Prefrontal Cortex BOLD Connectivity During Implicit Emotion Face Processing Task Over Time

"This outcome measure determines the extent to which irritability is characterized by dysfunctional threat processing during reproductive hormone challenge relative to baseline in HS+ and HS-. By examining amygdala-medial prefrontal cortex (PFC) Blood-oxygen-level-dependent (BOLD) connectivity in response to threatening faces on the implicit emotion face processing fMRI task in HS+ (compared with HS-) during hormone challenge relative to baseline.~The implicit emotion face processing task asks participants to identify the gender of angry, happy, and fearful faces at 50%, 100% and 150% emotion intensity presented in random order for 2000 milliseconds followed by jittered fixation. Trials appear in 3 blocks, generating 30 trials of each emotion at each intensity and 90 neutral face emotion trials." (NCT04051320)
Timeframe: up to 6 weeks

,
Interventionarbitrary units (Mean)
Baseline (Visit 3)Hormone Addback (Visit 6)
Hormone Insensitive Women (HS-)0.05330.00804
Hormone Sensitive Women (HS+)0.0174-0.0114

Mean Threat Processing Bias During Visual Dot-probe Paradigm Over Time

"This outcome measure determines the extent to which irritability is characterized by dysfunctional threat processing during reproductive hormone challenge relative to baseline in HS+ and HS- by examining threat attention bias assessed during the visual dot-probe paradigm.~The Visual Dot-Probe Paradigm asks participants to detect a target stimulus that is embedded in a matrix of distracting stimuli (e.g., a target stimulus, an angry face, might be embedded in a matrix of neutral distractor faces). Attention biases are inferred from faster response times to detect a threatening stimulus in a matrix of neutral stimuli relative to response time to detect neutral stimuli in neutral matrices. Thus, positive times reflect attention bias toward threat, whereas negative times reflect attention bias away from threat." (NCT04051320)
Timeframe: up to 6 weeks

,
Interventionattention bias in milliseconds (Mean)
Baseline (Visit 3)Hormone Addback (Visit 6)
Hormone Insensitive Women (HS-)36.92-42.35
Hormone Sensitive Women (HS+)-0.57-9.04

Reviews

5 reviews available for melatonin and Hypergonadotropic Hypogonadism

ArticleYear
The evidence for seasonal variations of testosterone in men.
    Maturitas, 2013, Volume: 74, Issue:3

    Topics: Body Mass Index; Circadian Rhythm; Humans; Hypogonadism; Male; Melatonin; Motor Activity; Seasons; S

2013
[Hormone therapy in the aging male. Estrogen, DHEA, melatonin, somatotropin].
    Der Urologe. Ausg. A, 2004, Volume: 43, Issue:9

    Topics: Aged; Aged, 80 and over; Aging; Dehydroepiandrosterone; Estrogens; Growth Hormone; Hormone Replaceme

2004
Sex, steroids, and sleep: a review.
    Sleep, 1999, Aug-01, Volume: 22, Issue:5

    Topics: Animals; Depressive Disorder; Female; gamma-Aminobutyric Acid; Gonadal Steroid Hormones; Humans; Hyp

1999
[Melatonin. I. Physiology of its secretion].
    Revue medicale de Liege, 2000, Volume: 55, Issue:8

    Topics: Alcoholism; Body Constitution; Circadian Rhythm; Cushing Syndrome; Electromagnetic Fields; Female; H

2000
[Certain results and perspectives of the study of the role of the epiphysis in obstetrics and gynecology (literature survey)].
    Akusherstvo i ginekologiia, 1974, Issue:5

    Topics: Female; Humans; Hypogonadism; Labor, Obstetric; Lactation; Melatonin; Menopause; Menstruation; Ovari

1974

Trials

1 trial available for melatonin and Hypergonadotropic Hypogonadism

ArticleYear
Abnormal melatonin secretion in hypogonadal men: the effect of testosterone treatment.
    Clinical endocrinology, 1997, Volume: 47, Issue:4

    Topics: Adolescent; Adult; Follicle Stimulating Hormone; Humans; Hypogonadism; Klinefelter Syndrome; Luteini

1997

Other Studies

22 other studies available for melatonin and Hypergonadotropic Hypogonadism

ArticleYear
Melatonin appears to protect against steroidogenic collapse in both mice fed with high-fat diet and H
    Andrologia, 2019, Volume: 51, Issue:8

    Topics: Animals; Cell Line; Cholesterol Side-Chain Cleavage Enzyme; Diet, High-Fat; Disease Models, Animal;

2019
[Investigation, treatment and monitoring of late-onset hypogonadism in males: the official guidelines of the International Society for the Study of the Study of the Aging Male (ISSAM) with comments].
    Annales d'endocrinologie, 2003, Volume: 64, Issue:4

    Topics: Aging; Androgens; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; France; Hormones; Human Gr

2003
Altered melatonin secretion in hypogonadal men: clinical evidence.
    International journal of andrology, 2005, Volume: 28, Issue:4

    Topics: Adolescent; Adult; Circadian Rhythm; Darkness; Follicle Stimulating Hormone; Humans; Hypogonadism; L

2005
Increased nocturnal melatonin secretion in male patients with hypogonadotropic hypogonadism and delayed puberty.
    The Journal of clinical endocrinology and metabolism, 1995, Volume: 80, Issue:7

    Topics: Activity Cycles; Adolescent; Cohort Studies; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate;

1995
The antigonadotrophic effect of melatonin in Syrian hamsters is modulated by prostaglandin.
    Journal of neural transmission. General section, 1994, Volume: 95, Issue:3

    Topics: Animals; Brain Chemistry; Circadian Rhythm; Cricetinae; Dinoprostone; Drug Administration Schedule;

1994
Daytime plasma melatonin levels in male hypogonadism.
    The Journal of clinical endocrinology and metabolism, 1996, Volume: 81, Issue:5

    Topics: Adult; Chorionic Gonadotropin; Circadian Rhythm; Dehydroepiandrosterone; Dehydroepiandrosterone Sulf

1996
Testosterone treatment alters melatonin concentrations in male patients with gonadotropin-releasing hormone deficiency.
    The Journal of clinical endocrinology and metabolism, 1996, Volume: 81, Issue:2

    Topics: Adolescent; Adult; Estradiol; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans;

1996
Nocturnal secretory patterns of melatonin, luteinizing hormone, prolactin and cortisol in male patients with gonadotropin-releasing hormone deficiency.
    Journal of pineal research, 1996, Volume: 21, Issue:1

    Topics: Adolescent; Adult; Circadian Rhythm; Gonadotropins; Humans; Hydrocortisone; Hypogonadism; Luteinizin

1996
Abnormal melatonin secretion in male patients with hypogonadism.
    Journal of molecular neuroscience : MN, 1996,Summer, Volume: 7, Issue:2

    Topics: Adolescent; Adult; Circadian Rhythm; Darkness; Estradiol; Follicle Stimulating Hormone; Gonadotropin

1996
Early morning melatonin levels in hypogonadal men.
    The Journal of clinical endocrinology and metabolism, 1996, Volume: 81, Issue:11

    Topics: Circadian Rhythm; Gonadal Steroid Hormones; Gonadotropin-Releasing Hormone; Gonadotropins; Humans; H

1996
Hypogonadotrophic hypogonadism and primary amenorrhoea associated with increased melatonin secretion from a cystic pineal lesion.
    Clinical endocrinology, 1996, Volume: 45, Issue:3

    Topics: Adolescent; Amenorrhea; Brain Diseases; Cysts; Female; Gonadotropins, Pituitary; Humans; Hypogonadis

1996
Pulsatile patterns of melatonin secretion in patients with gonadotropin-releasing hormone deficiency: effects of testosterone treatment.
    Journal of pineal research, 1997, Volume: 22, Issue:2

    Topics: Adolescent; Adult; Case-Control Studies; Gonadotropin-Releasing Hormone; Humans; Hypogonadism; Lutei

1997
Melatonin concentration before and during testosterone replacement in primary hypogonadic men.
    European journal of endocrinology, 1997, Volume: 137, Issue:1

    Topics: Adult; Circadian Rhythm; Humans; Hypogonadism; Male; Melatonin; Reference Values; Testosterone

1997
Effects of leuprolide-induced hypogonadism and testosterone replacement on sleep, melatonin, and prolactin secretion in men.
    The Journal of clinical endocrinology and metabolism, 1997, Volume: 82, Issue:10

    Topics: Adolescent; Adult; Body Temperature; Circadian Rhythm; Hormones; Humans; Hypogonadism; Leuprolide; M

1997
Effects of leuprolide-induced hypogonadism and testosterone replacement on sleep, melatonin, and prolactin secretion in men.
    The Journal of clinical endocrinology and metabolism, 1997, Volume: 82, Issue:10

    Topics: Adolescent; Adult; Body Temperature; Circadian Rhythm; Hormones; Humans; Hypogonadism; Leuprolide; M

1997
Effects of leuprolide-induced hypogonadism and testosterone replacement on sleep, melatonin, and prolactin secretion in men.
    The Journal of clinical endocrinology and metabolism, 1997, Volume: 82, Issue:10

    Topics: Adolescent; Adult; Body Temperature; Circadian Rhythm; Hormones; Humans; Hypogonadism; Leuprolide; M

1997
Effects of leuprolide-induced hypogonadism and testosterone replacement on sleep, melatonin, and prolactin secretion in men.
    The Journal of clinical endocrinology and metabolism, 1997, Volume: 82, Issue:10

    Topics: Adolescent; Adult; Body Temperature; Circadian Rhythm; Hormones; Humans; Hypogonadism; Leuprolide; M

1997
Effects of leuprolide-induced hypogonadism and testosterone replacement on sleep, melatonin, and prolactin secretion in men.
    The Journal of clinical endocrinology and metabolism, 1997, Volume: 82, Issue:10

    Topics: Adolescent; Adult; Body Temperature; Circadian Rhythm; Hormones; Humans; Hypogonadism; Leuprolide; M

1997
Effects of leuprolide-induced hypogonadism and testosterone replacement on sleep, melatonin, and prolactin secretion in men.
    The Journal of clinical endocrinology and metabolism, 1997, Volume: 82, Issue:10

    Topics: Adolescent; Adult; Body Temperature; Circadian Rhythm; Hormones; Humans; Hypogonadism; Leuprolide; M

1997
Effects of leuprolide-induced hypogonadism and testosterone replacement on sleep, melatonin, and prolactin secretion in men.
    The Journal of clinical endocrinology and metabolism, 1997, Volume: 82, Issue:10

    Topics: Adolescent; Adult; Body Temperature; Circadian Rhythm; Hormones; Humans; Hypogonadism; Leuprolide; M

1997
Effects of leuprolide-induced hypogonadism and testosterone replacement on sleep, melatonin, and prolactin secretion in men.
    The Journal of clinical endocrinology and metabolism, 1997, Volume: 82, Issue:10

    Topics: Adolescent; Adult; Body Temperature; Circadian Rhythm; Hormones; Humans; Hypogonadism; Leuprolide; M

1997
Effects of leuprolide-induced hypogonadism and testosterone replacement on sleep, melatonin, and prolactin secretion in men.
    The Journal of clinical endocrinology and metabolism, 1997, Volume: 82, Issue:10

    Topics: Adolescent; Adult; Body Temperature; Circadian Rhythm; Hormones; Humans; Hypogonadism; Leuprolide; M

1997
Effects of testosterone treatment on plasma melatonin levels in male hypogonadism.
    Clinical endocrinology, 1998, Volume: 48, Issue:5

    Topics: Female; Humans; Hypogonadism; Male; Melatonin; Testosterone

1998
Elevated nocturnal melatonin is a consequence of gonadotropin-releasing hormone deficiency in women with hypothalamic amenorrhea.
    The Journal of clinical endocrinology and metabolism, 1998, Volume: 83, Issue:10

    Topics: Adult; Amenorrhea; Circadian Rhythm; Cluster Analysis; Female; Follicle Stimulating Hormone; Gonadot

1998
The association between melatonin and sleep stages in normal adults and hypogonadal men.
    Sleep, 1999, Nov-01, Volume: 22, Issue:7

    Topics: Adolescent; Adult; Hormone Replacement Therapy; Humans; Hypogonadism; Male; Melatonin; Sleep Stages;

1999
Melatonin hypersecretion in male patients with adult-onset idiopathic hypogonadotropic hypogonadism.
    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2000, Volume: 108, Issue:2

    Topics: Adult; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Hypogonadism; Luteinizi

2000
Brief report: melatonin-related hypogonadotropic hypogonadism.
    The New England journal of medicine, 1992, Nov-05, Volume: 327, Issue:19

    Topics: Adult; Chorionic Gonadotropin; Follicle Stimulating Hormone; Gonadotropins, Pituitary; Humans; Hypog

1992
Melatonin--the hormone of darkness.
    The New England journal of medicine, 1992, Nov-05, Volume: 327, Issue:19

    Topics: Adolescent; Adult; Aged; Animals; Calcinosis; Child; Child, Preschool; Female; Humans; Hypogonadism;

1992
Rapid decrease in melatonin production during successful treatment of delayed puberty.
    Lancet (London, England), 1989, Jun-10, Volume: 1, Issue:8650

    Topics: Adolescent; Ethinyl Estradiol; Female; Humans; Hypogonadism; Melatonin; Puberty, Delayed; Specimen H

1989
Non-Cartesian pineal function.
    The New England journal of medicine, 1971, Feb-11, Volume: 284, Issue:6

    Topics: Animals; Female; Gonadotropins; Humans; Hypogonadism; Luteinizing Hormone; Male; Melatonin; Olfactio

1971